Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae

BACKGROUND: The efficacy of ceftazidime-avibactam—a cephalosporin–β-lactamase inhibitor combination with in vitro activity against Klebsiella pneumoniae carbapenemase–producing carbapenem-resistant Enterobacteriaceae (CRE)—compared with colistin remains unknown. METHODS: Patients initially treated w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: van Duin, David, Lok, Judith J, Earley, Michelle, Cober, Eric, Richter, Sandra S, Perez, Federico, Salata, Robert A, Kalayjian, Robert C, Watkins, Richard R, Doi, Yohei, Kaye, Keith S, Fowler, Vance G, Paterson, David L, Bonomo, Robert A, Evans, Scott
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Articles and Commentaries
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5850032/
https://ncbi.nlm.nih.gov/pubmed/29020404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix783
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados